1. Home
  2. EQBK vs GOSS Comparison

EQBK vs GOSS Comparison

Compare EQBK & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equity Bancshares Inc.

EQBK

Equity Bancshares Inc.

HOLD

Current Price

$44.82

Market Cap

870.8M

Sector

Finance

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.13

Market Cap

796.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQBK
GOSS
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
870.8M
796.2M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
EQBK
GOSS
Price
$44.82
$3.13
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$47.80
$8.60
AVG Volume (30 Days)
75.3K
4.5M
Earning Date
01-21-2026
11-05-2025
Dividend Yield
1.60%
N/A
EPS Growth
N/A
N/A
EPS
1.00
N/A
Revenue
$186,035,000.00
$44,051,000.00
Revenue This Year
$15.54
N/A
Revenue Next Year
$37.88
$6.41
P/E Ratio
$44.72
N/A
Revenue Growth
17.93
N/A
52 Week Low
$34.11
$0.76
52 Week High
$48.14
$3.87

Technical Indicators

Market Signals
Indicator
EQBK
GOSS
Relative Strength Index (RSI) 47.41 45.93
Support Level $45.00 $3.04
Resistance Level $45.71 $3.87
Average True Range (ATR) 1.30 0.29
MACD -0.36 -0.08
Stochastic Oscillator 11.98 11.45

Price Performance

Historical Comparison
EQBK
GOSS

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: